QUALIDADE DE VIDA NO TRABALHO: COM A PALAVRA OS FUNCIONÁRIOS PÚBLICOS

O tema desta pesquisa é a Qualidade de Vida no Trabalho dos funcionários públicos da Secretaria de Saúde de Barra Mansa/RJ. Trata-se de um estudo de caso de natureza quanti-qualitativa, exploratória e descritiva que tem como objetivos compreender o que é a QVT na ótica do funcionário público, verificar que percepções ele possui acerca de sua própria QVT e, a partir daí, compreender se na esfera pública é possível construir um novo sentido para a QVT que se aproxime de um compromisso com a coletividade e com a vida. O modelo de QVT de Walton, a análise dos instrumentos de onze outras pesquisas realizadas em diversas instituições brasileiras e a coleta de sete depoimentos dos sujeitos pesquisados, acerca de suas histórias profissionais, suas impressões gerais sobre a QVT, orientaram a elaboração do instrumento utilizado nesta pesquisa. Coletaram-se 205 questionários válidos quantidade suficiente para a utilização da análise fatorial como método estatístico, por meio do software SPSS , além de mais dois depoimentos, em entrevistas abertas, os quais, somados aos sete já obtidos por ocasião da preparação do instrumento de pesquisa, foram utilizados na análise qualitativa que também se fez. Os principais resultados encontrados apontam que a QVT dos funcionários públicos pesquisados é de razoável a boa e que eles associam QVT a uma série de aspectos objetivos e subjetivos da vida no trabalho. Muitos deles estão presentes no modelo de Walton, porém emergiram alguns que vão além do que o modelo abrange. É exatamente nesta lacuna que parece ser possível construir novos sentidos para a QVT que a aproximam de um compromisso com a coletividade e com a vida, numa lógica diferente daquela individualista e instrumental que marcam sua origem no setor privado. A partir daí se abre a possibilidade de se pensar em políticas públicas participativas.

QUALIDADE DE VIDA NO TRABALHO: COM A PALAVRA OS FUNCIONÁRIOS PÚBLICOS

O tema desta pesquisa é a Qualidade de Vida no Trabalho dos funcionários públicos da Secretaria de Saúde de Barra Mansa/RJ. Trata-se de um estudo de caso de natureza quanti-qualitativa, exploratória e descritiva que tem como objetivos compreender o que é a QVT na ótica do funcionário público, verificar que percepções ele possui acerca de sua própria QVT e, a partir daí, compreender se na esfera pública é possível construir um novo sentido para a QVT que se aproxime de um compromisso com a coletividade e com a vida. O modelo de QVT de Walton, a análise dos instrumentos de onze outras pesquisas realizadas em diversas instituições brasileiras e a coleta de sete depoimentos dos sujeitos pesquisados, acerca de suas histórias profissionais, suas impressões gerais sobre a QVT, orientaram a elaboração do instrumento utilizado nesta pesquisa. Coletaram-se 205 questionários válidos quantidade suficiente para a utilização da análise fatorial como método estatístico, por meio do software SPSS , além de mais dois depoimentos, em entrevistas abertas, os quais, somados aos sete já obtidos por ocasião da preparação do instrumento de pesquisa, foram utilizados na análise qualitativa que também se fez. Os principais resultados encontrados apontam que a QVT dos funcionários públicos pesquisados é de razoável a boa e que eles associam QVT a uma série de aspectos objetivos e subjetivos da vida no trabalho. Muitos deles estão presentes no modelo de Walton, porém emergiram alguns que vão além do que o modelo abrange. É exatamente nesta lacuna que parece ser possível construir novos sentidos para a QVT que a aproximam de um compromisso com a coletividade e com a vida, numa lógica diferente daquela individualista e instrumental que marcam sua origem no setor privado. A partir daí se abre a possibilidade de se pensar em políticas públicas participativas.

QUALIDADE DE VIDA NO TRABALHO: COM A PALAVRA OS FUNCIONÁRIOS PÚBLICOS

O tema desta pesquisa é a Qualidade de Vida no Trabalho dos funcionários públicos da Secretaria de Saúde de Barra Mansa/RJ. Trata-se de um estudo de caso de natureza quanti-qualitativa, exploratória e descritiva que tem como objetivos compreender o que é a QVT na ótica do funcionário público, verificar que percepções ele possui acerca de sua própria QVT e, a partir daí, compreender se na esfera pública é possível construir um novo sentido para a QVT que se aproxime de um compromisso com a coletividade e com a vida. O modelo de QVT de Walton, a análise dos instrumentos de onze outras pesquisas realizadas em diversas instituições brasileiras e a coleta de sete depoimentos dos sujeitos pesquisados, acerca de suas histórias profissionais, suas impressões gerais sobre a QVT, orientaram a elaboração do instrumento utilizado nesta pesquisa. Coletaram-se 205 questionários válidos quantidade suficiente para a utilização da análise fatorial como método estatístico, por meio do software SPSS , além de mais dois depoimentos, em entrevistas abertas, os quais, somados aos sete já obtidos por ocasião da preparação do instrumento de pesquisa, foram utilizados na análise qualitativa que também se fez. Os principais resultados encontrados apontam que a QVT dos funcionários públicos pesquisados é de razoável a boa e que eles associam QVT a uma série de aspectos objetivos e subjetivos da vida no trabalho. Muitos deles estão presentes no modelo de Walton, porém emergiram alguns que vão além do que o modelo abrange. É exatamente nesta lacuna que parece ser possível construir novos sentidos para a QVT que a aproximam de um compromisso com a coletividade e com a vida, numa lógica diferente daquela individualista e instrumental que marcam sua origem no setor privado. A partir daí se abre a possibilidade de se pensar em políticas públicas participativas.

Advertising for over-the-counter drugs : public record 215-51, 16 CFR part 450 : report of the presiding officer on proposed trade regulation rule /

Cover title.

Report of the medical officer of health for the colony on the public health ...

Title varies according to the scope of contents.

Engineer Stimer's report of the last trial trip of the "Passaic." Unparalleled attempt to throw discredit upon superiors. Language unbecoming an officer. His dismissal from the service demanded. The public probably deceived as to the "result" of the experiment of firing inside the turret.

Mode of access: Internet.

Past, present and the evolving future of public health and health promotion: Reflections on dismantling in Queensland Australia

Objective For more than ten years the public health and health promotion workforce in the Australian state of Queensland grew dramatically. This growth was most pronounced in the disciplines of Health Promotion and in Public Health Nutrition, both regionally and corporately. In 2012 political change led to an abrupt dismantling of its public and preventive health services across the state. Individual responsibility was declared. Method This presentation provides a qualitative narrative description of past achievements and activities, the current situation and provides a perspective towards the future. Findings Government reports over several years described the growing burden of chronic disease arising from conditions such as obesity, physical inactivity, and poor nutrition in Queensland. By 2008, obesity had overtaken smoking as the single greatest risk factor to the health of Queenslanders. In 2010, the Chief Health Officer called for an increased focus on prevention to address the continuing need for more beds in hospitals. However, with political change in 2012 resulted in the dismantling and dismissal of preventive health services across the state. The following year, despite outcry, sexual health services were also axed. At present, outbreaks of vaccine preventable diseases such as measles are occurring. The epidemics of chronic disease, obesity and physical inactivity continue to grow. Conclusion The evolution of public health is not necessarily progressive, but cyclic. Challenges include political change, health practice and the interplay of health policy. A lack of an embedded emphasis on systematic review translation is one potential contributor. Perhaps the warning of Lang & Rayner should be heeded: “public health proponents have allowed themselves to be corralled into the narrow language of individualism and choice”.

Turing and the Trans-Pacific Partnership: Intellectual Property, Public Health, and Access to Essential Medicines

A recent controversy in the United States over drug pricing by Turing Pharmaceuticals AG has raised larger issues in respect of intellectual property, access to medicines, and the Trans-Pacific Partnership (TPP). In August 2015, Turing Pharmaceuticals AG – a private biopharmaceutical company with offices in New York, the United States, and Zug, Switzerland - acquired the exclusive marketing rights to Daraprim in the United States from Impax Laboratories Incorporated. Martin Shkreli, Turing’s Founder and Chief Executive Officer, maintained: “The acquisition of Daraprim and our toxoplasmosis research program are significant steps along Turing’s path of bringing novel medications to patients with serious disorders, some of whom often go undiagnosed and untreated.” He emphasised: “We intend to invest in the development of new drug candidates that we hope will yield an even better clinical profile, and also plan to launch an educational effort to help raise awareness and improve diagnosis for patients with toxoplasmosis.” In September 2015, there was much public controversy over the decision of Martin Shkreli to raise the price of a 62 year old drug, Daraprim, from $US13.50 to $US750 a pill. The drug is particularly useful in respect to the treatment and prevention of malaria, and in the treatment of infections in individuals with HIV/AIDS. Daraprim is listed on the World Health Organization’s (WHO) List of Essential Medicines. In the face of much criticism, Martin Shkreli has said that he will reduce the price of Daraprim. He observed: “We've agreed to lower the price on Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit.” He maintained: “We think these changes will be welcomed.” However, he has been vague and ambiguous about the nature of the commitment. Notably, the lobby group, Pharmaceutical Research and Manufacturers of America (PhARMA), disassociated itself from the claims of Turing Pharmaceuticals. The group said: “PhRMA members have a long history of drug discovery and innovation that has led to increased longevity and improved lives for millions of patients.” The group noted: “Turing Pharmaceutical is not a member of PhRMA and we do not embrace either their recent actions or the conduct of their CEO.” The biotechnology peak body Biotechnology Industry Organization also sought to distance itself from Turing Pharmaceuticals. A hot topic: United States political debate about access to affordable medicines This controversy over Daraprim is unusual – given the age of drug concerned. Daraprim is not subject to patent protection. Nonetheless, there remains a monopoly in respect of the marketplace. Drug pricing is not an isolated problem. There have been many concerns about drug pricing – particularly in respect of essential medicines for HIV/AIDS, tuberculosis, and malaria. This recent controversy is part of a larger debate about access to affordable medicines. The dispute raises larger issues about healthcare, consumer rights, competition policy, and trade. The Daraprim controversy has provided impetus for law reform in the US. US Presidential Candidate Hillary Clinton commented: “Price gouging like this in this specialty drug market is outrageous.” In response to her comments, the Nasdaq Biotechnology Index fell sharply. Hillary Clinton has announced a prescription drug reform plan to protect consumers and promote innovation – while putting an end to profiteering. On her campaign site, she has emphasised that “affordable healthcare is a basic human right.” Her rival progressive candidate, Bernie Sanders, was also concerned about the price hike. He wrote a letter to Martin Shkreli, complaining about the price increase for the drug Daraprim. Sanders said: “The enormous, overnight price increase for Daraprim is just the latest in a long list of skyrocketing price increases for certain critical medications.” He has pushed for reforms to intellectual property to make medicines affordable. The TPP and intellectual property The Daraprim controversy and political debate raises further issues about the design of the TPP. The dispute highlights the dangers of extending the rights of pharmaceutical drug companies under intellectual property, investor-state dispute settlement, and drug administration. Recently, the civil society group Knowledge Ecology International published a leaked draft of the Intellectual Property Chapter of the TPP. Knowledge Ecology International Director, James Love, was concerned the text revealed that the US “continues to be the most aggressive supporter of expanded intellectual property rights for drug companies.” He was concerned that “the proposals contained in the TPP will harm consumers and in some cases block innovation.” James Love feared: “In countless ways, the Obama Administration has sought to expand and extend drug monopolies and raise drug prices.” He maintained: “The astonishing collection of proposals pandering to big drug companies make more difficult the task of ensuring access to drugs for the treatment of cancer and other diseases and conditions.” Love called for a different approach to intellectual property and trade: “Rather than focusing on more intellectual property rights for drug companies, and a death-inducing spiral of higher prices and access barriers, the trade agreement could seek new norms to expand the funding of medical research and development (R&D) as a public good, an area where the US has an admirable track record, such as the public funding of research at the National Institutes of Health (NIH) and other federal agencies.” In addition, there has been much concern about the Investment Chapter of the TPP. The investor-state dispute settlement regime would enable foreign investors to challenge government policy making, which affected their investments. In the context of healthcare, there is a worry that pharmaceutical drug companies will deploy their investor rights to challenge public health measures – such as, for instance, initiatives to curb drug pricing and profiteering. Such concerns are not merely theoretical. Eli Lilly has brought an investor action against the Canadian Government over the rejection of its drug patents under the investor-state dispute settlement regime of the North American Free Trade Agreement (NAFTA). The Health Annex to the TPP also raises worries that pharmaceutical drug companies will able to object to regulatory procedures in respect of healthcare. It is disappointing that the TPP – in the leaks that we have seen – has only limited recognition of the importance of access to essential medicines. There is a need to ensure that there are proper safeguards to provide access to essential medicines – particularly in respect of HIV/AIDs, malaria, and tuberculosis. Moreover, there must be protection against drug profiteering and price gouging in any trade agreement. There should be strong measures against the abuse of intellectual property rights. The dispute over Turing Pharmaceuticals AG and Daraprim is an important cautionary warning in respect of some of the dangers present in the secret negotiations in respect of the TPP. There is a need to preserve consumer rights, competition policy, and public health in trade negotiations over an agreement covering the Pacific Rim.

Houston police officer attitudes towards the mentally ill: CIT trained and non-CIT trained

The purpose of this study was to develop a better understanding of police officer attitudes towards the mentally ill and what impact that might have on their behavior. Focused on the effects of Crisis Intervention Team (CIT) training on Houston police officers, this research wanted to determine if CIT training decreases attitudes of authoritarianism and increases attitudes of self-efficacy in dealing with the mentally ill—other factors assessed were age, years of service, ethnicity, and gender. Results confirmed that CIT training had an effect on an officer's attitudes with CIT officers being less authoritarian and having more self-efficacy with respect to dealing with the mentally ill as compared to non-CIT officers. Because of these results, this study could offer support in tailoring training programs to have successful officer-mentally ill person interactions. ^

Shlaudeman nomination : hearings before the Committee on Foreign Relations, United States Senate, Ninety-fourth Congress, second session, on the nomination of Harry W. Shlaudeman, of California, a Foreign Service officer of class 1, to be Assistant Secretary of State for Inter-American Affairs, May 25, and June 10 and 11, 1976.

Includes bibliographical references.

The officer's manual. Military maxims of Napoleon.

Contains 68 maxims, annotated by M. Burnod.

Report of the presiding officer on proposed trade regulation rule concerning funeral industry practices : [16 C.F.R. part 453], United States of America before Federal Trade Commission /

Mode of access: Internet.

Picturesque United States of America, 1811, 1812, 1813, being a memoir on Paul Svinin, Russian diplomatic officer, artist, and author, containing copious excerpts from his account of his travels in America, with fifty-two reproductions of water colors in his own sketch-book,

"A list of the editions of Svinin's pamphlet on General Moreau": p.45-46.